Genascence Corporation, a clinical-stage biotechnology company, has appointed Jeymi Tambiah, MBChB, FRCS, MS, FAPCR, MFPM(Dis) as its chief medical officer.   Tambiah is an accomplished physician-scientist with more than 15 years of biopharmaceutical industry experience creating and leading strategies for medical affairs, clinical development, and drug development programs. He also brings deep experience in translational medicine, commercialization, and health outcomes research to Genascence. ...